How We Built PANGEA-SMM to Predict Progression to Myeloma
SMM is a blood cancer precursor defined by "watchful waiting." Predicting if and when a patient will progress remains a major challenge, as current "snapshot" models lack precision. We developed PANGEA-SMM to track dynamic data and personalize the decision of when to safely start therapy.
